Cornerstone Research has consulted with attorneys on government-initiated criminal and civil claims stemming from the alleged off-label marketing of major drugs.
Cornerstone Research has consulted with attorneys on government-initiated criminal and civil claims stemming from the alleged off-label marketing of major drugs. These suits are centered on allegations that the off-label marketing resulted in prescriptions that would not have otherwise been written, caused false claims to be submitted to government healthcare programs, and that the marketing activities are a violation of the Federal Food, Drug, and Cosmetic Act. In these cases Cornerstone Research has extensive experience analyzing large databases, assessing factors that may have led doctors to prescribe the drugs for off-label indications, and determining economic causation.